Annual EBITDA
-$125.94 M
+$88.63 M+41.30%
December 31, 2023
Summary
- As of February 8, 2025, PRAX annual EBITDA is -$125.94 million, with the most recent change of +$88.63 million (+41.30%) on December 31, 2023.
- During the last 3 years, PRAX annual EBITDA has fallen by -$64.02 million (-103.40%).
- PRAX annual EBITDA is now -379.34% below its all-time high of -$26.27 million, reached on December 31, 2018.
Performance
PRAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$56.74 M
-$19.36 M-51.80%
September 30, 2024
Summary
- As of February 8, 2025, PRAX quarterly EBITDA is -$56.74 million, with the most recent change of -$19.36 million (-51.80%) on September 30, 2024.
- Over the past year, PRAX quarterly EBITDA has dropped by -$14.97 million (-35.83%).
- PRAX quarterly EBITDA is now -658.19% below its all-time high of -$7.48 million, reached on December 31, 2019.
Performance
PRAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$163.59 M
-$31.34 M-23.69%
September 30, 2024
Summary
- As of February 8, 2025, PRAX TTM EBITDA is -$163.59 million, with the most recent change of -$31.34 million (-23.69%) on September 30, 2024.
- Over the past year, PRAX TTM EBITDA has dropped by -$33.86 million (-26.10%).
- PRAX TTM EBITDA is now -1436.95% below its all-time high of -$10.64 million, reached on September 30, 2019.
Performance
PRAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PRAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.3% | -35.8% | -26.1% |
| 3 y3 years | -103.4% | -49.4% | +11.0% |
| 5 y5 years | -379.3% | -49.4% | +11.0% |
PRAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.3% | -123.3% | +17.5% | -29.9% | +29.6% |
| 5 y | 5-year | -252.3% | +41.3% | -658.2% | +17.5% | -802.4% | +29.6% |
| alltime | all time | -379.3% | +41.3% | -658.2% | +17.5% | -1437.0% | +29.6% |
Praxis Precision Medicines EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$56.74 M(+51.8%) | -$163.59 M(+23.7%) |
| Jun 2024 | - | -$37.38 M(-10.5%) | -$132.26 M(+1.9%) |
| Mar 2024 | - | -$41.77 M(+50.8%) | -$129.73 M(+3.0%) |
| Dec 2023 | -$125.94 M(-41.3%) | -$27.70 M(+9.0%) | -$125.94 M(-9.8%) |
| Sep 2023 | - | -$25.41 M(-27.1%) | -$139.59 M(-11.9%) |
| Jun 2023 | - | -$34.85 M(-8.2%) | -$158.38 M(-13.8%) |
| Mar 2023 | - | -$37.98 M(-8.1%) | -$183.80 M(-14.3%) |
| Dec 2022 | -$214.57 M(+28.4%) | -$41.35 M(-6.4%) | -$214.57 M(-7.4%) |
| Sep 2022 | - | -$44.19 M(-26.7%) | -$231.78 M(-0.2%) |
| Jun 2022 | - | -$60.27 M(-12.3%) | -$232.33 M(+11.4%) |
| Mar 2022 | - | -$68.76 M(+17.4%) | -$208.51 M(+24.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$167.15 M(+170.0%) | -$58.56 M(+30.9%) | -$167.15 M(+24.5%) |
| Sep 2021 | - | -$44.73 M(+22.7%) | -$134.28 M(+27.0%) |
| Jun 2021 | - | -$36.46 M(+33.1%) | -$105.75 M(+30.8%) |
| Mar 2021 | - | -$27.40 M(+6.6%) | -$80.86 M(+30.6%) |
| Dec 2020 | -$61.92 M(+73.2%) | -$25.69 M(+58.5%) | -$61.92 M(+41.7%) |
| Sep 2020 | - | -$16.21 M(+40.2%) | -$43.71 M(+14.6%) |
| Jun 2020 | - | -$11.56 M(+36.7%) | -$38.15 M(+43.5%) |
| Mar 2020 | - | -$8.46 M(+13.0%) | -$26.59 M(+46.7%) |
| Dec 2019 | -$35.75 M(+36.1%) | -$7.48 M(-29.7%) | -$18.13 M(+70.3%) |
| Sep 2019 | - | -$10.64 M | -$10.64 M |
| Dec 2018 | -$26.27 M | - | - |
FAQ
- What is Praxis Precision Medicines annual EBITDA?
- What is the all time high annual EBITDA for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual EBITDA year-on-year change?
- What is Praxis Precision Medicines quarterly EBITDA?
- What is the all time high quarterly EBITDA for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly EBITDA year-on-year change?
- What is Praxis Precision Medicines TTM EBITDA?
- What is the all time high TTM EBITDA for Praxis Precision Medicines?
- What is Praxis Precision Medicines TTM EBITDA year-on-year change?
What is Praxis Precision Medicines annual EBITDA?
The current annual EBITDA of PRAX is -$125.94 M
What is the all time high annual EBITDA for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual EBITDA is -$26.27 M
What is Praxis Precision Medicines annual EBITDA year-on-year change?
Over the past year, PRAX annual EBITDA has changed by +$88.63 M (+41.30%)
What is Praxis Precision Medicines quarterly EBITDA?
The current quarterly EBITDA of PRAX is -$56.74 M
What is the all time high quarterly EBITDA for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly EBITDA is -$7.48 M
What is Praxis Precision Medicines quarterly EBITDA year-on-year change?
Over the past year, PRAX quarterly EBITDA has changed by -$14.97 M (-35.83%)
What is Praxis Precision Medicines TTM EBITDA?
The current TTM EBITDA of PRAX is -$163.59 M
What is the all time high TTM EBITDA for Praxis Precision Medicines?
Praxis Precision Medicines all-time high TTM EBITDA is -$10.64 M
What is Praxis Precision Medicines TTM EBITDA year-on-year change?
Over the past year, PRAX TTM EBITDA has changed by -$33.86 M (-26.10%)